Microbial models of mammalian metabolism.
A solid basis for the M4-approach has been developed over the past 10 years. Recent examples of the production of difficult-to-synthesize mammalian metabolites through microbial transformations attest to the utility of the methodology. There is, however, much more to be done. Model studies should be conducted to test parallels between microbial and mammalian S- and N-oxidations, O-glucuronidations, and ester and amide hydrolyses. Subsequently, even greater applications of M4- work can be envisioned. We have been pleased to see our colleagues in industry and academia adopt the M4- approach to solve difficult pharmacological and toxicological problems. In large measure, this has been our greatest reward for efforts initially presented before the membership of the American Society of Pharmacognosy in 1973.
D000175:Acronine / Q000378:metabolism; D000818:Animals; D001058:Apomorphine / Q000031:analogs & derivatives / Q000378:metabolism; D001711:Biotransformation; D003640:Dealkylation; D004611:Ellipticines / Q000378:metabolism; D004873:Ergolines / Q000031:analogs & derivatives / Q000378:metabolism; D006168:Guinea Pigs; D006801:Humans; D006900:Hydroxylation; D007099:Imipramine / Q000378:metabolism; D008322:Mammals / Q000378:metabolism*; D008954:Models, Biological; D010208:Papaverine / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*
D004611:Ellipticines; D004873:Ergolines; D004364:Pharmaceutical Preparations; D010208:Papaverine; D001058:Apomorphine; C031875:lergotrile; C006613:apocodeine; D007099:Imipramine; D000175:Acronine